Tamsulosin Hydrochloride
Product Images NDC 67046-721

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 67046-721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tam0.4.721

This is a label of a medicine bottle containing 30 capsules of Tamsulosin, each with a dosage of 0.4 mg. The GTIN code is 00367046721307, and the lot number is TMSA18257-A. The pill identifier is D53. The medicine is manufactured by CitronRising and contains Tamsulosin Hydrochloride USP. It is a controlled substance and should be stored in a room temperature of 20-25°C. The NDC number is 67046-721-30.*

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

The text is a figure caption depicting a graph of mean plasma concentrations of Tamsulosin Hydrochloride Capsules 0.4 mg under fasted and fed conditions over time. Therefore, it doesn't provide any useful description of the data presented in the graph.*

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

The text is a description of a figure depicting the mean change from baseline in Total AUA Symptom Score (ranging from 0 to 35) in Study 1. The figure shows the treatment (0.08mg A, 0.4mg A, and placebo), mean change, and the duration of treatment weeks (ranging from 0 to 13). Raw scan data is present in the figure.*

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

The figure shows the mean increase in peak urine flow rate (in L/Sec) in Study 1. The treatment groups were 0.08 mg and 0.4 mg, and the placebo group. The mean change in mL/sec is depicted, and the duration of treatment was in weeks. There were different numbers of participants in each group for the duration of treatment.*

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

This appears to be a graph with the title "Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2". There are two axes with values, the X-axis representing "Duration of Treatment (weeks)" and the Y-axis representing "Mean Increase in Peak Urine Flow Rate (mL/Sec)". There are also bars indicating data points for different treatments, but without further context it is difficult to determine the specifics.*

FDA Label Image

Chemical Structure (Tamsulosin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.